These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21048011)

  • 1. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.
    Gu J; Xu W; Lei L; Huang J; Feng X; Sun C; Du C; Zuo J; Li Y; Du T; Li L; Han W
    J Clin Microbiol; 2011 Jan; 49(1):111-7. PubMed ID: 21048011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
    Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus.
    Xia F; Li X; Wang B; Gong P; Xiao F; Yang M; Zhang L; Song J; Hu L; Cheng M; Sun C; Feng X; Lei L; Ouyang S; Liu ZJ; Li X; Gu J; Han W
    Appl Environ Microbiol; 2016 Jan; 82(1):87-94. PubMed ID: 26475103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation.
    Zhang L; Li D; Li X; Hu L; Cheng M; Xia F; Gong P; Wang B; Ge J; Zhang H; Cai R; Wang Y; Sun C; Feng X; Lei L; Han W; Gu J
    Sci Rep; 2016 Jul; 6():29344. PubMed ID: 27385518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ointment Consisting of the Phage Lysin LysGH15 and Apigenin for Decolonization of Methicillin-Resistant
    Cheng M; Zhang L; Zhang H; Li X; Wang Y; Xia F; Wang B; Cai R; Guo Z; Zhang Y; Ji Y; Sun C; Feng X; Lei L; Yang Y; Han W; Gu J
    Viruses; 2018 May; 10(5):. PubMed ID: 29734776
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
    Daniel A; Euler C; Collin M; Chahales P; Gorelick KJ; Fischetti VA
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1603-12. PubMed ID: 20086153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.
    Wang Z; Kong L; Liu Y; Fu Q; Cui Z; Wang J; Ma J; Wang H; Yan Y; Sun J
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625989
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
    Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
    J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysin.
    Gu J; Feng Y; Feng X; Sun C; Lei L; Ding W; Niu F; Jiao L; Yang M; Li Y; Liu X; Song J; Cui Z; Han D; Du C; Yang Y; Ouyang S; Liu ZJ; Han W
    PLoS Pathog; 2014 May; 10(5):e1004109. PubMed ID: 24831957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
    Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice.
    Gu J; Zuo J; Lei L; Zhao H; Sun C; Feng X; Du C; Li X; Yang Y; Han W
    Bioeng Bugs; 2011; 2(2):96-9. PubMed ID: 21636996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lytic activity of recombinant phage lysin LysKΔamidase against staphylococcal strains associated with bovine and human infections in the Jiangsu province of China.
    Zhou Y; Zhang H; Bao H; Wang X; Wang R
    Res Vet Sci; 2017 Apr; 111():113-119. PubMed ID: 28235706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
    Hamed ZO; Awni AA; Abdulamir AS
    Arch Microbiol; 2023 Mar; 205(4):104. PubMed ID: 36869962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of the lytic domain of endolysin from Staphylococcus aureus bacteriophage in milk.
    Yan J; Yang R; Yu S; Zhao W
    J Dairy Sci; 2021 Mar; 104(3):2641-2653. PubMed ID: 33358804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.
    Matsuzaki S; Yasuda M; Nishikawa H; Kuroda M; Ujihara T; Shuin T; Shen Y; Jin Z; Fujimoto S; Nasimuzzaman MD; Wakiguchi H; Sugihara S; Sugiura T; Koda S; Muraoka A; Imai S
    J Infect Dis; 2003 Feb; 187(4):613-24. PubMed ID: 12599078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.
    Pastagia M; Euler C; Chahales P; Fuentes-Duculan J; Krueger JG; Fischetti VA
    Antimicrob Agents Chemother; 2011 Feb; 55(2):738-44. PubMed ID: 21098252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.
    Duan XC; Li XX; Li XM; Wang S; Zhang FQ; Qian P
    Microbiol Spectr; 2023 Jun; 11(3):e0505022. PubMed ID: 37125939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections.
    Gupta R; Prasad Y
    Curr Microbiol; 2011 Jan; 62(1):255-60. PubMed ID: 20607539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo.
    Yang H; Zhang Y; Yu J; Huang Y; Zhang XE; Wei H
    Antimicrob Agents Chemother; 2014; 58(1):536-42. PubMed ID: 24189265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
    Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
    J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.